| P2093 | author name string | Paul M Lieberman | |
| | Fang Lu | |
| | Horng-Shen Chen | |
| P2860 | cites work | The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome | Q40516561 |
| | Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. | Q40635375 |
| | Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. | Q40705440 |
| | Methylation of the Epstein-Barr virus genome in normal lymphocytes | Q41075320 |
| | CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease | Q41158549 |
| | Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2) | Q41370670 |
| | The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains | Q41860564 |
| | Chromatin profiling of Epstein-Barr virus latency control region | Q41867337 |
| | Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency | Q41947834 |
| | Unexpected structure of Epstein-Barr virus lytic cycle activator Zta. | Q42160761 |
| | Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas | Q42656894 |
| | EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication | Q43505203 |
| | Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma | Q43813156 |
| | Pheno- and genotypic features of Epstein-Barr virus associated B-cell lymphoproliferations in peripheral T-cell lymphomas. | Q54449917 |
| | Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays | Q73344152 |
| | Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1 | Q24520598 |
| | Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes | Q24538878 |
| | An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions | Q24614360 |
| | CTCF: master weaver of the genome | Q24621388 |
| | Brd4 links chromatin targeting to HPV transcriptional silencing | Q24676251 |
| | Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association | Q27643414 |
| | A bivalent chromatin structure marks key developmental genes in embryonic stem cells | Q27860977 |
| | Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization | Q28243346 |
| | The structure and function of SMC and kleisin complexes | Q28256179 |
| | Epigenotypes of latent herpesvirus genomes | Q28257829 |
| | Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes | Q28258520 |
| | Two faces of brd4: mitotic bookmark and transcriptional lynchpin | Q28278777 |
| | The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation | Q28290625 |
| | Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein | Q28472387 |
| | KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA | Q28474913 |
| | Cancer epigenetics: from mechanism to therapy | Q29614799 |
| | Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency | Q33545232 |
| | The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. | Q33598569 |
| | AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome | Q33640163 |
| | Epigenetic analysis of KSHV latent and lytic genomes | Q33641399 |
| | Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates. | Q33653017 |
| | CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp | Q33668727 |
| | CpG-methylation regulates a class of Epstein-Barr virus promoters | Q33707736 |
| | Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 |
| | DNA methylation and the Epstein-Barr virus | Q33765683 |
| | Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance | Q33786506 |
| | The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies | Q33815705 |
| | Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1. | Q33826947 |
| | Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). | Q33841257 |
| | BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. | Q33843046 |
| | Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus | Q33865166 |
| | Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication | Q33941808 |
| | EBV latency types adopt alternative chromatin conformations | Q33987454 |
| | Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation | Q34005284 |
| | Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway | Q34092628 |
| | Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. | Q34092739 |
| | Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes | Q34106764 |
| | The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation | Q34130213 |
| | A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. | Q34179693 |
| | Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR | Q34340317 |
| | The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter | Q34359380 |
| | Phosphorylation of the chromatin binding domain of KSHV LANA | Q34456086 |
| | The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas | Q34549462 |
| | Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. | Q34648229 |
| | Cohesin: genomic insights into controlling gene transcription and development | Q34762370 |
| | The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection | Q35077558 |
| | Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes | Q35080523 |
| | Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 |
| | Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses | Q35101324 |
| | Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest | Q35139294 |
| | The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites | Q35666071 |
| | Persistence of the Epstein-Barr virus and the origins of associated lymphomas | Q35715171 |
| | Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen | Q35774091 |
| | Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. | Q35787708 |
| | Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA | Q35943531 |
| | Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. | Q35943718 |
| | The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA | Q36086767 |
| | Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency | Q36538689 |
| | Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. | Q36555784 |
| | Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs | Q36564877 |
| | Cohesin regulation: fashionable ways to wear a ring | Q36749404 |
| | Lytic cycle switches of oncogenic human gammaherpesviruses | Q36786043 |
| | The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4 | Q36994613 |
| | The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. | Q37114836 |
| | Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes | Q37127891 |
| | The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency | Q37380228 |
| | Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication | Q37476243 |
| | The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes | Q37583383 |
| | Does CTCF mediate between nuclear organization and gene expression? | Q37658609 |
| | Epigenetic reprogramming of host genes in viral and microbial pathogenesis | Q37781197 |
| | Why do viruses cause cancer? Highlights of the first century of human tumour virology | Q37811898 |
| | Cohesin: a critical chromatin organizer in mammalian gene regulation | Q37919509 |
| | The bromodomain interaction module | Q38019699 |
| | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays | Q38305362 |
| | Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability | Q38318452 |
| | Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile | Q38321333 |
| | Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats | Q39320195 |
| | BRD4 jump-starts transcription after mitotic silencing | Q39435811 |
| | Evidence that protein binding specifies sites of DNA demethylation | Q39444301 |
| | The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus | Q39559198 |
| | Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. | Q39580375 |
| | Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. | Q39596964 |
| | Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. | Q39612221 |
| | Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). | Q39647281 |
| | Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies | Q39666008 |
| | Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores | Q39675686 |
| | The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency | Q39732626 |
| | The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation | Q39743627 |
| | Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas | Q39744147 |
| | Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. | Q39776571 |
| | Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation | Q39804470 |
| | The reversal of epigenetic silencing of the EBV genome is regulated by viral bZIP protein | Q39960898 |
| | Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus | Q39983012 |
| | Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators | Q40020777 |
| | Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes | Q40048949 |
| | High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1. | Q40131153 |
| | KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity | Q40286016 |
| | The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. | Q40318272 |
| P433 | issue | 3 | |
| P304 | page(s) | 251-259 | |
| P577 | publication date | 2013-04-16 | |
| P1433 | published in | Current opinion in virology | Q26842394 |
| P1476 | title | Epigenetic regulation of EBV and KSHV latency | |
| P478 | volume | 3 | |